Panic disorder is a condition that affects many people around the world. It causes sudden episodes of intense fear, often called panic attacks.
During these attacks, people may feel like they cannot breathe, their heart is racing, or something terrible is about to happen. These feelings can be very frightening and can interfere with daily life.
Doctors usually treat panic disorder with medications such as clonazepam, which helps calm the brain. However, not everyone responds well to these treatments, and some people experience side effects.
Now, scientists have discovered that a well-known antibiotic called minocycline may offer a new way to treat panic disorder. This finding comes from research carried out at São Paulo State University and the Federal University of Rio de Janeiro. The results were published in the journal Translational Psychiatry.
Minocycline is normally used to treat bacterial infections. It has been used safely for many years. However, researchers became interested in it for a different reason. They found that, at low doses, minocycline can reduce inflammation in the brain. Inflammation in nerve cells has been linked to several mental health conditions, including panic disorder.
To test this idea, scientists conducted experiments in both animals and humans. In mice, they used a special method to trigger panic-like reactions by exposing them to high levels of carbon dioxide.
This gas creates a feeling similar to suffocation, which can trigger panic. Mice that were treated with minocycline for two weeks showed fewer panic-related behaviors compared to those that did not receive the drug.
The researchers also tested the drug in human participants. They studied 49 patients who had been diagnosed with panic disorder. These patients inhaled air containing a high level of carbon dioxide to trigger panic symptoms.
Some patients were treated with minocycline, while others received clonazepam. Doctors carefully measured their anxiety levels before and after treatment.
The results showed that minocycline reduced the intensity of panic attacks in a way similar to clonazepam. This is important because clonazepam can cause side effects such as drowsiness, slower breathing, and dependence. Minocycline works in a different way and may avoid some of these issues.
Further analysis showed that patients who took minocycline had lower levels of certain inflammatory substances in their bodies. These substances are linked to stress and immune responses. At the same time, levels of anti-inflammatory substances increased. This supports the idea that reducing inflammation may help improve panic symptoms.
The study also looked at a specific part of the brain called the locus coeruleus. This area is sensitive to carbon dioxide and plays a role in panic reactions. In mice, minocycline reduced the activity of immune cells in this region, which may explain its calming effect.
Although these results are promising, the researchers stress that more studies are needed. This was an early-stage study, and larger clinical trials are required to confirm the findings. However, the fact that minocycline is already widely used and considered safe makes it a strong candidate for further research.
In conclusion, this study suggests that minocycline could become a new option for treating panic disorder, especially for people who do not respond well to existing medications. It also highlights the important role of inflammation in mental health conditions.
While more research is needed, the findings open the door to new treatment approaches that focus on the immune system as well as the brain.
If you care about nutrition, please read studies that ultra-processed foods may make you feel depressed, and Vitamin D could help reduce depression symptoms.
For more information about nutrition, please see recent studies about antioxidants that could help reduce the risk of dementia, and Omega-3 supplements could improve memory functions in older people.
Source: São Paulo State University.
